4.3 Article

Biochemical pathways of breath ammonia (NH3) generation in patients with end-stage renal disease undergoing hemodialysis

期刊

JOURNAL OF BREATH RESEARCH
卷 10, 期 3, 页码 -

出版社

IOP PUBLISHING LTD
DOI: 10.1088/1752-7155/10/3/036011

关键词

ammonia; breath analysis; end stage renal disease; laser spectroscopy; hemodialysis

资金

  1. Eli Lilly
  2. Roche
  3. Astellas
  4. Fresenius
  5. Novartis

向作者/读者索取更多资源

Breath ammonia (NH3) has been proposed as a potential biomarker in monitoring hemodialysis (HD) adequacy, since a strong correlation between blood urea and mouth-exhaled breath NH3 has been observed in patients with end-stage renal disease (ESRD) undergoing HD. However, the biochemical pathways for breath NH3 generation from blood urea have not been demonstrated. In this study, we show a strong correlation (rs = 0.77, p < 0.001) between blood and salivary urea, indicating that salivary urea levels reflect blood urea levels. Salivary urea is in turn strongly correlated to salivary ammonia (NH4+ + NH3) in most of the patients. This confirms that the hydrolysis of urea by urease generates ammonia in the oral cavity. A further strong correlation between salivary ammonia and breath NH3 indicates that salivary ammonia evaporates into gas phase and turns to breath NH3. Therefore, blood urea is a major biochemical source of breath NH3. Since breath NH3 is generated predominantly in the oral cavity, the levels of breath NH3 are influenced significantly by the patient's oral condition including urease activity and salivary pH. Our results agree with previous studies that have shown a connection between salivary urea and breath NH3.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据